Special Issue "Advances in Ginsenosides"
Deadline for manuscript submissions: closed (29 February 2020) | Viewed by 62956
A printed edition of this Special Issue is available here.
Interests: bioactive compounds; chromatography techniques; medicinal plants; phytochemicals; plant biotechnology; plant growth regulators; plant secondary metabolites
Special Issues, Collections and Topics in MDPI journals
Special Issue in Biomolecules: Phytochemical Omics in Medicinal Plants
Special Issue in Biomolecules: In Silico Studies via Big Data for Revealing Plant Signaling
Special Issue in International Journal of Molecular Sciences: Cell Signaling in Model Plants
Special Issue in International Journal of Molecular Sciences: Orchid Biochemistry 2.0
Special Issue in Biomolecules: Dietary Supplements and Functional Foods: Molecular Aspects and Integrative Omics
Special Issue in International Journal of Molecular Sciences: Molecular Aspects of Plant Salinity Stress and Tolerance
Special Issue in International Journal of Molecular Sciences: Cell Signaling in Model Plants 2.0
Special Issue in Journal of Fungi: Molecular Aspects of Medicinal Fungi
Special Issue in Biomolecules: Phytochemical Omics in Medicinal Plants 2.0
Special Issue in Biomolecules: Advances in Ginsenosides 2.0
Special Issue in International Journal of Molecular Sciences: Advances in Horticultural Research Based on Multi-Omics and Computational Biology
Special Issue in International Journal of Molecular Sciences: Cell Signaling in Model Plants 3.0
Special Issue in International Journal of Molecular Sciences: Molecular Aspects of Plant Salinity Stress and Tolerance 2.0
Special Issue in International Journal of Molecular Sciences: Plant Metabolomics: Uncovering the Hidden World of Plant Secondary Metabolites
Special Issue in International Journal of Molecular Sciences: Orchid Biochemistry 3.0
Ginsenosides, also known as ginseng saponins or triterpene saponins, are the foremost bioactive constituents of ginseng which belongs to the Panax genus. The genus name Panax means “all-curing” in Greek, and Panax ginseng Meyer has been used as a top-grade herb in traditional Chinese medicine or the king of tonic for over 2000 years in oriental countries. Ginseng preparation possesses a wide range of benefits on human health, including enhancing immune function, improving circulation and vascular function, prevention of neurological diseases, modulation of metabolism, and improving vitality and health. Ginsenosides are unique to ginseng species, and there are more than 100 ginsenosides that have been identified. Ginsenosides have a variety of biological activities, such as neuroprotection, antioxidation, anticancer, antistress, anti-inflammatory, antiaging, antifatigue, cytotoxicity, inhibiting cell apoptosis, inhibiting platelet aggregation. Recent studies on the therapeutic potential of ginsenosides reveal the molecular mechanisms on cardiovascular diseases, anti-inflammatory, modulation of the endocrine system, immune system diseases, and nervous system diseases. In brief, ginsenosides possess complicated bioactive effects and regulate multiple metabolic pathways, and therefore, their efficacy is interconnected and difficult to be clarified.
This Special Issue aims to integrate recent innovative approaches and attempt to make significant progress in biochemistry of ginsenosides by expanding knowledge on a wide range of topics, including biotechnology, biosynthetic machinery, pharmacognostical and pharmacological studies, the application of high-throughput technologies such as genomics, transcriptomics, proteomics, metabolomics, and bioinformatics and other related topics. I sincerely invite scientists to contribute both original research articles and reviews on this Special issue.
Dr. Jen-Tsung Chen
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- bioactive compounds
- biosynthetic machinery
- high-throughput technologies